On 2025-08-07, C4 Therapeutics, Inc. (CCCC) announced earnings per share of $-0.37 for the fiscal quarter ending 2025-06-30, beating the average analyst estimate of $-0.38.
The next expected annoucement date for quarterly earnings is 2025-10-30, with an average estimated earnings per share of $-0.47 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-07 | 2025-06-30 | $-0.38 | $-0.37 |
| 2025-05-07 | 2025-03-31 | $-0.48 | $-0.37 |
| 2025-02-27 | 2024-12-31 | $-0.44 | $-0.49 |
| 2024-10-31 | 2024-09-30 | $-0.40 | $-0.35 |
| 2024-08-01 | 2024-06-30 | $-0.37 | $-0.26 |
| 2024-05-08 | 2024-03-31 | $-0.41 | $-0.41 |
| 2024-02-22 | 2023-12-31 | $-0.67 | $-0.68 |
| 2023-11-01 | 2023-09-30 | $-0.65 | $-0.55 |
| 2023-08-08 | 2023-06-30 | $-0.74 | $-0.73 |
| 2023-05-04 | 2023-03-31 | $-0.78 | $-0.71 |
| 2023-02-23 | 2022-12-31 | $-0.72 | $-0.76 |
| 2022-11-03 | 2022-09-30 | $-0.65 | $-0.65 |
| 2022-08-04 | 2022-06-30 | $-0.68 | $-0.56 |
| 2022-05-05 | 2022-03-31 | $-0.61 | $-0.65 |
| 2022-02-24 | 2021-12-31 | $-0.59 | $-0.31 |
| 2021-11-10 | 2021-09-30 | $-0.60 | $-0.51 |
| 2021-08-11 | 2021-06-30 | $-0.60 | $-0.51 |
| 2021-05-13 | 2021-03-31 | $-0.63 | $-0.49 |
| 2020-11-12 | 2020-09-30 | $-1.16 | $-17.55 |